Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors that are harmful to human health. Increasing evidence has underscored the critical role of the competitive endogenous RNA (ceRNA) regulatory networks among various human cancers. However, the complexity and behavior characterist...
Saved in:
Main Authors: | Yi Shi (Author), Dan-Dan Zhang (Author), Ji-Bin Liu (Author), Xiao-Li Yang (Author), Rui Xin (Author), Cheng-You Jia (Author), Hui-Min Wang (Author), Gai-Xia Lu (Author), Pei-Yao Wang (Author), Yu Liu (Author), Zi-Jin Li (Author), Jing Deng (Author), Qin-Lu Lin (Author), Liang Ma (Author), Shan-Shan Feng (Author), Xiao-Qi Chen (Author), Xiang-Min Zheng (Author), Ya-Fu Zhou (Author), Yong-Jun Hu (Author), Hua-Qun Yin (Author), Lin-Lin Tian (Author), Li-Peng Gu (Author), Zhong-Wei Lv (Author), Fei Yu (Author), Wen Li (Author), Yu-Shui Ma (Author), Fu Da (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
by: Qiao-Li Lv, et al.
Published: (2020) -
Ste20-Like Kinase TAOK1 Positively Regulates Antiviral Responses by Controlling the TBK1-IRF3 Signaling Axis
by: Xiaogang Luo, et al.
Published: (2023) -
Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma
by: Dan-Dan Zhang, et al.
Published: (2021) -
Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis
by: Yu-Shui Ma, et al.
Published: (2020) -
Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis
by: Yu-Shui Ma, et al.
Published: (2022)